samedan logo

 
 
spacer
home > ebr > spring 2003 > the biosaxony region
PUBLICATIONS
European Biopharmaceutical Review

The biosaxony Region

"There's one thing I am certain of... Saxony will soon be Germany's main biotechnology centre..." - Professor Guenter Blobel (Nobel Prize for Medicine, 1999)

Should every nation, state, city, town and village develop their own biotechnology cluster? What is biosaxony and how could it possibly be different from the many other bio-locations? As you read this article, hopefully you will agree that there are unique elements to biosaxony that justify taking a closer look. First there are the people; the ready availability of a highly trained and motivated workforce with (together with Portugal) the lowest labour rates in Europe. Rates will stay low as Eastern Europe opens up in 2004 and the availability of skilled labour is further supplemented.

Next there is the infrastructure - the most modern in Europe with 100 per cent digital communication systems and fibre-optic networks, gas, electricity and waste disposal functionality at green field locations, as well as modern roads, airports and rail networks which have all been rebuilt within the last 10 years.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Ivan Baines, Partner at Biopolis Consultants

Dr Baines received his PhD in Cell Biology and Biochemistry from University College London in 1988 and performed postdoctoral and independent research at the National Institutes of Health (USA). He then joined the National Heart, Lung and Blood Institute (NHLBI) to help administer its $2.8 billion budget for basic and clinical life sciences research.

While promoting the NHLBI's Small Business Innovation Research (SBIR) award programme, Dr Baines advised over 100 new start-ups within life sciences. He also helped turn the revenue balance of the NHLBI's patent portfolio from loss to profit in under two years. Dr Baines helped to set up and run the Max Planck Institute for Molecular Cell Biology and Genetics in Dresden as Scientific Co-ordinator and Director of Services and Facilities, before co-founding Biopolis Consultants in 2001.

spacer
Dr Ivan Baines
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo keeps growing steadily.

According to the international air cargo information provider WACD's September data, the global air cargo brand Turkish Cargo, which serves 126 countries of the world, grew significantly by achieving a tonnage increase of 8.8 percent in a sector wherein the global air cargo market shrank by -5.4 percent.
More info >>

White Papers

Inhaler Adherence: Exploring Key Factors

Aptar Pharma

Aptar Pharma recently hosted an expert panel roundtable on “Inhaler Adherence”. This international scientific forum was held in Paris, France on November 29th 2013. The roundtable was organized to explore and exchange views on the issues which may influence inhaler adherence/ compliance with a particular focus on asthma and C.O.P.D. therapies and their corresponding inhaler devices (MDIs, DPIs).
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

23-26 March 2020, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 23 – 26 March 2020. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement